EQUIOXX IMPORTANT SAFETY INFORMATION: As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. A veterinarian should advise horse owners to observe for signs of potential drug toxicity. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EQUIOXX has not been tested in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares.
SURPASS IMPORTANT SAFETY INFORMATION: Like any medication, non-steroidal anti-inflammatory drugs (NSAIDs) such as SURPASS may cause side effects. These are usually mild and affect primarily the gastrointestinal system, but more serious side effects can occur, such as diarrhea and renal toxicity. NSAIDs should only be administered under the direction of a licensed professional. SURPASS topical cream is only approved for use in horses and has not been evaluated in breeding, pregnant, or lactating horses, or in horses under 1 year of age. Do not exceed the recommended dose. Wear gloves when administering SURPASS. If direct contact with skin occurs, wash immediately with soap and water. Please refer to the package insert for complete product information.
LEGEND IMPORTANT SAFETY INFORMATION: The safety of LEGEND has not been evaluated in breeding stallions or in breeding, pregnant or lactating mares. The following adverse reactions have been reported following use of LEGEND Injectable Solution: Following intravenous use: occasional depression, lethargy, and fever. Following intra-articular (LEGEND Injectable Solution — 2 mL only) use: lameness, joint effusion, joint or injection site swelling, and joint pain. LEGEND 4 mL and LEGEND Multi-Dose Injectable Solution are administered by intravenous injection only.
HYALOVET IMPORTANT SAFETY INFORMATION: Not for human use. HYALOVET Injection must not be administered intravascularly. As with any intra-articular injection, a mild inflammatory response may be seen in the joint following HYALOVET injection. The response is self-limiting but may last from 2 to 5 days after treatment. If inflammation is excessive or severe, the possibility of infection should be considered and appropriate antibiotic therapy instituted
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
HYVISC IMPORTANT SAFETY INFORMATION: A mild inflammatory response may occur post injection. For intra-articular injection in horses only. Do not use in horses intended for food.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
EQUIOXX®, SURPASS®, and LEGEND® are registered trademarks of Boehringer Ingelheim Animal Health USA Inc. HYALOVET® is a registered trademark of TRB Chemedica International S.A., Geneva Switzerland, used under license. HYVISC® is a registered trademark of Anika Therapeutics, Inc, used under license. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0114-2021